Lv0
0 积分 2023-02-13 加入
CAR-T cell persistence in the treatment of leukemia and lymphoma
1天前
待确认
Clinical lessons learned from the first leg of the CAR T cell journey
2天前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
13天前
已完结
Synthetic cytokine circuits that drive T cells into immune-excluded tumors
15天前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
15天前
已完结
Considerations for design, manufacture, and delivery for effective and safe T-cell engager therapies
24天前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
24天前
已完结
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
24天前
已完结
Synthesis and sorting of proteoglycans
27天前
已关闭
Natural killer cell therapies
1个月前
已完结
皖公网安备34019202002308
